Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction

Journal of Cardiology

Volumn 69, Issue 1, 2017, Pages 394-400

  Fuijkschot, Wessel W ^a,b   Groothuizen, Wouter E ^a   Appelman, Yolande ^a,b   Radonic, Teodora ^a   van Royen, Niels ^a,b   van Leeuwen, Maarten A H ^a,b   Krijnen, Paul A J ^a,b   van der Wal, Allard C ^c   Smulders, Yvo M ^a,b   Niessen, Hans W M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular; Immunohistochemistry; Inflammation; Myocardial ischemia; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CREATINE KINASE MB; AUTACOID; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PTPRC PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY RISK; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; NEUTROPHIL; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURFACE AREA; THROMBOCYTE COUNT; THROMBUS ASPIRATION; AGED; COMPLICATION; PATHOLOGY; ST ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE; TIME FACTOR;

AGED; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD PLATELETS; CORONARY THROMBOSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUTROPHILS; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS;

EID: 85006284541     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2016.10.003     Document Type: Article

References (29)

1. [1] Davies, M.J., Thomas, A.C., Plaque fissuring – the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53 (1985), 363–373.
2. [2] Yunoki, K., Naruko, T., Sugioka, K., Inaba, M., Itoh, A., Haze, K., Yoshiyama, M., Ueda, M., Thrombus aspiration therapy and coronary thrombus components in patients with acute ST-elevation myocardial infarction. J Atheroscler Thromb 20 (2013), 524–537.
3. [3] Ramaiola, I., Padro, T., Pena, E., Juan-Babot, O., Cubedo, J., Martin-Yuste, V., Sabate, M., Badimon, L., Changes in thrombus composition and profilin-1 release in acute myocardial infarction. Eur Heart J 36 (2015), 965–975.
4. [4] Sadowski, M., Zabczyk, M., Undas, A., Coronary thrombus composition: links with inflammation, platelet and endothelial markers. Atherosclerosis 237 (2014), 555–561.
5. [5] Silvain, J., Collet, J.P., Nagaswami, C., Beygui, F., Edmondson, K.E., Bellemain-Appaix, A., Cayla, G., Pena, A., Brugier, D., Barthelemy, O., Montalescot, G., Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 57 (2011), 1359–1367.
6. [6] Rittersma, S.Z., van der Wal, A.C., Koch, K.T., Piek, J.J., Henriques, J.P., Mulder, K.J., Ploegmakers, J.P., Meesterman, M., de Winter, R.J., Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 111 (2005), 1160–1165.
7. [7] Kramer, M.C., van der Wal, A.C., Koch, K.T., Rittersma, S.Z., Li, X., Ploegmakers, H.P., Henriques, J.P., van der Schaaf, R.J., Baan, J. Jr., Vis, M.M., Meesterman, M.G., Piek, J.J., Tijssen, J.G., de Winter, R.J., Histopathological features of aspirated thrombi after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. PLoS One, 4, 2009, e5817.
8. [8] Altmann, J., Sharma, S., Lang, I.M., Advances in our understanding of mechanisms of venous thrombus resolution. Expert Rev Hematol 9 (2016), 69–78.
9. [9] Saha, P., Smith, A., Regulation of sterile inflammation in the natural resolution of venous thrombosis. Thromb Haemost, 114, 2015, 875.
10. [10] Carol, A., Bernet, M., Curos, A., Rodriguez-Leor, O., Serra, J., Fernandez-Nofrerias, E., Mauri, J., Bayes-Genís, A., Thrombus age, clinical presentation, and reperfusion grade in myocardial infarction. Cardiovasc Pathol 23 (2014), 126–130.
11. [11] Nishimura, S., Ehara, S., Hasegawa, T., Matsumoto, K., Yoshikawa, J., Shimada, K., Cholesterol crystal as a new feature of coronary vulnerable plaques: an optical coherence tomography study. J Cardiol, 2016 [Elsevier: Please update], May 4.
12. [12] Kubo, T., Ino, Y., Matsuo, Y., Shiono, Y., Kameyama, T., Yamano, T., Katayama, Y., Taruya, A., Nishiguchi, T., Satogami, K., Kashiyama, K., Orii, M., Kuroi, A., Yamaguchi, T., Tanaka, A., et al. Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: an optical coherence tomography study. J Cardiol, 2016, 10.1016/j.jjcc.2016.04.005.
13. [13] Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
14. [14] Steg, P.G., James, S.K., Atar, D., Badano, L.P., Blömstrom-Lundqvist, C., Borger, M.A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A.H., Giannuzzi, P., Halvorsen, S., Huber, K., et al., Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33 (2012), 2569–2619.
15. [15] Maier, W., Altwegg, L.A., Corti, R., Gay, S., Hersberger, M., Maly, F.E., Sütsch, G., Roffi, M., Neidhart, M., Eberli, F.R., Tanner, F.C., Gobbi, S., von Eckardstein, A., Lüscher, T.F., Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111 (2005), 1355–1361.
16. [16] Frangogiannis, N.G., Smith, C.W., Entman, M.L., The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002), 31–47.
17. [17] Nijmeijer, R., Lagrand, W.K., Baidoshvili, A., Lubbers, Y.T., Hermens, W.T., Meijer, C.J., Visser, C.A., Hack, C.E., Niessen, H.W., Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans. Cardiovasc Res 53 (2002), 138–146.
18. [18] Hoshiba, Y., Hatakeyama, K., Tanabe, T., Asada, Y., Goto, S., Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 4 (2006), 114–120.
19. [19] Arakawa, K., Yasuda, S., Hao, H., Kataoka, Y., Morii, I., Kasahara, Y., Kawamura, A., Ishibashi-Ueda, H., Miyazaki, S., Significant association between neutrophil aggregation in aspirated thrombus and myocardial damage in patients with ST-segment elevation acute myocardial infarction. Circ J 73 (2009), 139–144.
20. [20] Steiner, I., Spacek, J., Matejkova, A., Vojacek, J., Bis, J., Dusek, J., Histopathology of aspirated thrombi during primary percutaneous coronary intervention in patients with acute myocardial infarction. Cardiovasc Pathol 23 (2014), 267–271.
21. [21] Li, X., de Boer, O.J., Ploegmaker, H., Teeling, P., Daemen, M.J., de Winter, R.J., van der Wal, A.C., Granulocytes in coronary thrombus evolution after myocardial infarction - time-dependent changes in expression of matrix metalloproteinases. Cardiovasc Pathol 25 (2016), 40–46.
22. [22] Soo, K.S., Northeast, A.D., Happerfield, L.C., Burnand, K.G., Bobrow, L.G., Tissue plasminogen activator production by monocytes in venous thrombolysis. J Pathol 178 (1996), 190–194.
23. [23] Zeng, S., Zhou, X., Ge, L., Ji, W.J., Shi, R., Lu, R.Y., Sun, H.Y., Guo, Z.Z., Zhao, J.H., Jiang, T.M., Li, Y.M., Monocyte subsets and monocyte-platelet aggregates in patients with unstable angina. J Thromb Thrombolysis 38 (2014), 439–446.
24. [24] Gruver, A.L., Hudson, L.L., Sempowski, G.D., Immunosenescence of ageing. J Pathol 211 (2007), 144–156.
25. [25] van der Meer, M.G., Nathoe, H.M., van der, G.Y., Doevendans, P.A., Appelman, Y., Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest 45 (2015), 226–235.
26. [26] Kovacs, A., Sotonyi, P., Nagy, A.I., Tenekedjiev, K., Wohner, N., Komorowicz, E., Kovács, E., Nikolova, N., Szabó, L., Kovalszky, I., Machovich, R., Szelid, Z., Becker, D., Merkely, B., Kolev, K., Ultrastructure and composition of thrombi in coronary and peripheral artery disease: correlations with clinical and laboratory findings. Thromb Res 135 (2015), 760–766.
27. [27] Patrono, C., Ciabattoni, G., Patrignani, P., Pugliese, F., Filabozzi, P., Catella, F., Davì, G., Forni, L., Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 72 (1985), 1177–1184.
28. [28] Jain, M.K., Ridker, P.M., Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4 (2005), 977–987.
29. [29] Montecucco, F., Mach, F., Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol 31 (2009), 127–142.